A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis

by Rutgeerts, Paul J, Fedorak, Richard N, Hommes, Daan W, Sturm, Andreas, Baumgart, Daniel C, Bressler, Brian, Schreiber, Stefan, Mansfield, John C, Williams, Marna, Tang, Meina, Visich, Jennifer, Wei, Xiaohui, Keir, Mary, Luca, Diana, Danilenko, Dimitri, Egen, Jackson, O'Byrne, Sharon
Published 2013

Farnesoid X Receptor (FXR) Activation and FXR Genetic Variation in Inflammatory Bowel Disease

by Nijmeijer, Rian M., Gadaleta, Raffaella M., van Mil, Saskia W. C., van Bodegraven, Adriaan A., Crusius, J. Bart A., Dijkstra, Gerard, Hommes, Daan W., de Jong, Dirk J., Stokkers, Pieter C. F., Verspaget, Hein W., Weersma, Rinse K., van der Woude, C. Janneke, Stapelbroek, Janneke M., Schipper, Marguerite E. I., Wijmenga, Cisca, van Erpecum, Karel J., Oldenburg, Bas
Published 2011